glp-1 drugs kidney disease agonists in the treatment of chronic in type 2 diabetes and obesity Glucagon-like Peptide-1 Receptor Agonists and
Description
( 10.1111/dom.14553) [DOI] [PMC free article] [PubMed] [Google Scholar] Withaar C, Meems LMG, Markousis-Mavrogenis G, Boogerd CJ, Sillje HHW, Schouten EM, Dokter MM, Voors AA, Westenbrink BD, Lam CSP, et al
[DOI] [PubMed] [Google Scholar] 57.Alhajahjeh A, Al-Faouri R, Bahmad HF, Bader T, Dobbs RW, Abdulelah AA, et al
But every one of these medications works best as part of a broader plan that includes diet and activity, and none is right for everyone
[DOI] [PubMed] [Google Scholar] 124.Lundgren JR, et al
Power, E
(2022, June 2)
